[{"Assets_0_FY_USD":79954000000.0,"StockholdersEquity_0_FY_USD":25241000000.0,"RevenuesConverted_1_FY_USD":5569000000.0,"RevenuesConverted_4_FY_USD":22849000000.0,"NetIncomeLossConverted_4_FY_USD":1979000000.0,"NetIncomeLossConverted_1_FY_USD":-4264000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":735000000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":11177000000.0,"EarningsPerShareDiluted_1_FY_USD":-5.89,"EarningsPerShareBasic_4_FY_USD":2.71,"EarningsPerShareBasic_1_FY_USD":-5.89,"CommonStockSharesOutstanding_0_FY_shares":722200000.0,"CommonStockDividendsPerShareDeclared_1_FY_USD":1.32,"CommonStockDividendsPerShareCashPaid_1_FY_USD":1.15,"EarningsPerShareDiluted_4_FY_USD":2.69,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":731000000.0,"Ticker":"AMGN","CIK":"318154","name":"AMGEN INC","OfficialName":"Amgen Inc. Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"135245000000.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"SP500","filed":"20180213"}]